Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 2 16.: Difference between revisions
From GxPlex
imported>GxPlexBot Import from GxPlex Excel |
gxplex>GxPlexBot Import from GxPlex Excel |
(No difference)
| |
Revision as of 17:29, 15 July 2026
| Document information | |
|---|---|
| Reference | GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 |
| Validity area | GBR |
| Scope(s) | HM |
| Document name | The Medicines for Human Use (Clinical Trials) Regulations 2004 |
| Version / Revision | 01-May-2004 |
| Status | Current |
| Document type | Legal act |
| Language(s) | EN |
| Description | The Medicines for Human Use (Clinical Trials) Regulations 2004 |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
| Reference Details | |
|---|---|
| Module | Module 5 — Unit 5.5.0 |
| Scope | HM |
| Document part | Schedule 1
Part 2 16. |
| Language | EN |
| Original entry by | Florian Adragna |
| Contributors | |
| Tags | Insurance, Requirements, Sponsor, Investigator |
| Comment | Indemnity and insurance provision requirements |
Content
CONDITIONS AND PRINCIPLES WHICH APPLY TO ALL CLINICAL TRIALS […] 16. Provision has been made for insurance or indemnity to cover the liability of the investigator and sponsor which may arise in relation to the clinical trial.
